Aurobindo Pharma's US subsidiary gets US FDA's Official Action Indicated classification
CNBC-TV18

The US FDA has classified the inspection of Aurobindo Pharma's step-down
subsidiary Lannett Company LLC as OAI after issuing four observations during
an August inspection. Aurobindo Pharma said it responded to the observations
within the stipulated time and that the regulatory action has no impact on its
financials or operations.








